A single center, open study of Nebilet [nebivolol] 5 mg to evaluate the change in the cold test as a marker of the endothelial dysfunction change (EDEN I study)

Trial Profile

A single center, open study of Nebilet [nebivolol] 5 mg to evaluate the change in the cold test as a marker of the endothelial dysfunction change (EDEN I study)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Mar 2008

At a glance

  • Drugs Nebivolol (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Acronyms EDEN-I
  • Most Recent Events

    • 13 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top